← Back to Search

Other

I. for Infertility (FORT-T Trial)

N/A
Waitlist Available
Led By Richard H. Reindollar, M.D.
Research Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at end of study
Awards & highlights

FORT-T Trial Summary

This study will determine the most effective treatment strategy for infertile couples who present when the female partner is 38 years to the 43rd birthday and the couples are determined to have a reasonable chance for success.

FORT-T Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at end of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and at end of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Associated complications of treatment will be described.
Secondary outcome measures
Demographics and baseline variables will be collected, including: medical and reproductive, history, age, education, income, race, nutritional history, smoking history, and clinical variables related to infertility diagnosis and treatment.

FORT-T Trial Design

3Treatment groups
Active Control
Group I: I.Active Control2 Interventions
Those randomized to have clomiphene/IUI treatments first will initiate therapy with two cycles of the fertility pill called clomiphene combined with (IUI) intrauterine insemination. If not pregnant after 2 IUI cycles, the couples will then proceed to IVF.
Group II: II.Active Control2 Interventions
Those randomized to have gonadotropins/IUI treatments first will initiate therapy with two cycles of the fertility injections called FSH or gonadotropins combined with (IUI) intrauterine insemination. If not pregnant after 2 IUI cycles, the couples will then proceed to IVF.
Group III: III.Active Control1 Intervention
Those couples randomized to (IVF) in vitro fertilization will bypass IUI treatments and start IVF therapy immediately.

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Lead Sponsor
1,976 Previous Clinical Trials
2,680,216 Total Patients Enrolled
32 Trials studying Infertility
16,609 Patients Enrolled for Infertility
Richard H. Reindollar, M.D.Principal InvestigatorChair, Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, New Hampshire
1 Previous Clinical Trials
503 Total Patients Enrolled
1 Trials studying Infertility
503 Patients Enrolled for Infertility

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Molecular Cancer TherapeuticsJournal
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–resistant Melanoma
Nassar, Kelsey W., Jennifer D. Hintzsche, Stacey M. Bagby, Veronica Espinoza, Christophe Langouët-Astrié, Carol M. Amato, Tugs-Saikhan Chimed, et al.. 2021. “Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–resistant Melanoma”. Molecular Cancer Therapeutics. American Association for Cancer Research (AACR). doi:10.1158/1535-7163.mct-20-1126.
clinicaltrials.govStudy
Infertility Therapy for Women Age Thirty-eight and Older
2003. "Infertility Therapy for Women Age Thirty-eight and Older". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00246506.
All > Fertility > Infertility
~21 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top